United Therapeutics sues FDA, HHS to get orphan drug designation for Orenitram – Washington Business Journal

By Super UserAugust 11, 2017News

Home » United Therapeutics sues FDA, HHS to get orphan drug designation for Orenitram – Washington Business Journal

The company alleges the U.S. Food and Drug Administration isn’t honoring a drug designation program Congress passed in 1983.

{iframe}https://www.bizjournals.com/washington/news/2017/08/07/one-of-md-s-biggest-biotechs-sues-the-feds-to.html{/iframe}